U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07112105) titled 'Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder' on July 25.
Brief Summary: The purpose of this study is to establish a new treatment (repetitive transcranial stimulation (rTMS)) for Veterans with stimulant use disorder (SUD). Despite the large public health burden imposed by SUD, there is currently no FDA-approved or widely recognized effective somatic treatment. This placebo controlled study will test the effectiveness of rTMS in the treatment of SUD, and explore biomarkers that may guide patient selection for rTMS treatment and predict treatment response.
Study Start Date: Jan. 01, 2026
Study Typ...